A case series of re-establishment of neuromuscular block with rocuronium after sugammadex reversal

Journal of Anesthesia

Volumn 30, Issue 3, 2016, Pages 534-537

  Iwasaki, Hajime ^a   Sasakawa, Tomoki ^a   Takahoko, Kenichi ^a   Takagi, Shunichi ^b   Nakatsuka, Hideki ^c   Suzuki, Takahiro ^d   Iwasaki, Hiroshi ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c KAWASAKI MEDICAL SCHOOL   (Japan)

^d NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Repeat surgery; Rocuronium; Sugammadex

Indexed keywords

PROPOFOL; REMIFENTANIL; ROCURONIUM; SUGAMMADEX; ANDROSTANE DERIVATIVE; GAMMA CYCLODEXTRIN DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; CASE STUDY; CLINICAL ARTICLE; DRUG ANTAGONISM; ENDOTRACHEAL INTUBATION; FEMALE; GENERAL ANESTHESIA; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR MONITORING; TIME; PROCEDURES;

ADULT; AGED; ANDROSTANOLS; ANESTHESIA, GENERAL; FEMALE; GAMMA-CYCLODEXTRINS; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS;

EID: 84960082330     PISSN: 09138668     EISSN: 14388359     Source Type: Journal    
DOI: 10.1007/s00540-016-2159-4     Document Type: Article

References (17)

1. Bom A, Bradley M, Cameron K, Clark JK, Van Egmond J, Feilden H, MacLean EJ, Muir AW, Palin R, Rees DC, Zhang MQ. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl. 2002;41:266–70.
2. Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg. 2007;104:575–81.
3. Plaud B, Meretoja O, Hofmockel R, Raft J, Stoddart PA, van Kuijk JHM, Hermens Y, Mirakhur RK. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Anesthesiology. 2009;110:284–94.
4. Groudine SB, Soto R, Lien C, Drover D, Roberts K. A randomized, dose-finding, phase II study of the selective relaxant binding drug, Sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg. 2007;104:555–62.
5. de Boer HD, Driessen JJ, Marcus MAE, Kerkkamp H, Heeringa M, Klimek M. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex—a multicenter, dosefinding and safety study. Anesthesiology. 2007;107:239–44.
6. −1 in anaesthetized healthy volunteers: a modelling-based pilot study. Br J Anaesth. 2010;105:487–92.
7. Matsuki G, Takahata O, Iwasaki H. Repeat dosing of rocuronium after reversal of neuromuscular block by sugammadex. Can J Anaesth. 2011;58:769–70.
8. Fabregat-Lopez J, Veiga-Ruiz G, Dominguez-Serrano N, Garcia-Martinez MR. Re-establishment of neuromuscular block by rocuronium after sugammadex administration. Can J Anaesth. 2011;58:658–9.
9. Gijsenbergh F, Ramael S, Houwing N, van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology. 2005;103:695–703.
10. Grayling M, Sweeney BP. Recovery from neuromuscular blockade: a survey of practice. Anaesthesia. 2007;62:806–9.
11. Di Marco P, Della Rocca G, Iannuccelli F, Pompei L, Reale C, Pietropaoli P. Knowledge of residual curarization: an Italian survey. Acta Anaesthesiol Scand. 2010;54:307–12.
12. Futter M, Gin T. Neuromuscular block: views from the Western Pacific. Anesth Analg. 2010;111:11–2.
13. Kotake Y, Ochiai R, Suzuki T, Ogawa S, Takagi S, Ozaki M, Nakatsuka I, Takeda J. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg. 2013;117:345–51.
14. Pongracz A, Szatmari S, Nemes R, Fulesdi B, Tassonyi E. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation. Anesthesiology. 2013;119:36–42.
15. Schaller SJ, Fink H, Ulm K, Blobner M. Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block. Anesthesiology. 2010;113:1054–60.
16. Donati F. Sugammadex: an opportunity for more thinking or more cookbook medicine? Can J Anaesth. 2007;54:689–95.
17. de Boer HD, Driessen JJ, van Egmond J, Booij LH. Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex. Can J Anaesth. 2008;55:124–5 (author reply 5–6).